Breaking News on Pharmaceutical Technology

On your radar > Globalisation

Globalisation

When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.

GEA strikes Scandinavian representation deal with Christian Berner

08-Mar-2011 - GEA Pharma Systems, the German drug processing equipment manufacturer, has signed a representation agreement with Swedish hi-tech firm Christian Berner Tech Trade.

Cadila JV to set up plant in Rwanda

07-Mar-2011 - CSM GlobalPharma has announced plans to invest $65m in a manufacturing facility in Kigali, Rwanda in collaboration with the Rwandan Development Board (RDB).

WHO approval of SFDA to boost global vaccine supplies

03-Mar-2011 - The WHO expects global vaccine supplies will benefit significantly after it approved the Chinese SFDA regulatory system.

SOHM expands Indian manufacturing capacity for drugs for “lifestyle diseases”

01-Mar-2011 - Generic drugmaker SOHM has expanded its manufacturing capacity for “lifestyle” diseases to meet growing Indian demand.

Clarient launches Pharma packaging colour unit

24-Feb-2011 - Clariant International has set up a unit to help the pharma sector overcome regulatory hurdles involved with developing colour packaging

Mass-market pharma may build profit making supply chains

24-Feb-2011 - Mass-market drug manufacturers can turn a fixed cost into a service-providing revenue generator by investing in an agile supply chain, says PwC.

AstraZeneca to be “in Russia for Russia” with $150m plant

22-Feb-2011 - AstraZeneca has become the latest drug firm to invest in Russian manufacturing capcity with the announcment of plans for a $150m facility in the country’s Kaluga region.

Radical overhaul of ill-equipped pharma supply chains needed

22-Feb-2011 - A radical overhaul of pharmaceutical supply chains is needed to prepare them for the type of products currently in development, says PwC.

HHS national vaccine plan calls for quick, flexible production

21-Feb-2011 - The US HHS has published a national vaccine plan that stresses the need for rapid and flexible manufacturing methods.

West’s operating profit tumbles as restructuring charges hit

21-Feb-2011 - Operating profit at West tumbled in the fourth quarter as restructuring charges and the lack of H1N1 affected results.

European Parliament votes yes on falsified medicines directive

17-Feb-2011 - The European Parliament has approved the falsified medicines directive and described it as a “huge step” in efforts to protect patients.

Sanofi to buy Genzyme for $20.1bn and performance-based CVR

16-Feb-2011 - French drugmaker Sanofi Aventis will buy Genzyme after the firms finally agree a valuation based on manufacturing performance, approvals and sales.

Daiichi Sankyo acquires first US-based packaging and manufacturing facility

16-Feb-2011 - Japanese pharma giant, Daiichi Sankyo Inc. (DSI) has announced the acquisition of its first US-based packaging and manufacturing plant.

Merck Serono opens state-of-the-art research centre in Massachusetts.

16-Feb-2011 - EMD Serono Inc., an affiliate of pharma giant Merck, has announced the opening of a new research centre in Massachusetts, US.

Canada lost more than 3,600 pharma jobs in H2 2010

16-Feb-2011 - Canada lost more than 3,600 pharmaceutical jobs in the second half of 2010 as domestic and export sales slowed.

Shamla announces deal to build Saudi facility

15-Feb-2011 - Shamla Pharmaceutical Industries has announced it will build a manufacturing facility in King Abdullah Economic City (KAEC), Saudi Arabia.

Pharma demand helps Gerresheimer to a record 2010 FY

14-Feb-2011 - Gerresheimer has reported sales and earnings growth for the fiscal year 2010, citing demand from customers in the pharmaceutical industry as key.

Batch variation has implications for developing world

14-Feb-2011 - Variation between drug batches in developing countries poses “serious clinical implications” and should be tackled by regulators.

Novasep and instrAction team on taxane process development

09-Feb-2011 - Novasep and instrAction have partnered to develop improved methods for the production of taxane-based active pharmaceutical ingredients (API) citing growing demand for cancer treatments as key driver.

USP launches drug quality programme in sub-Saharan Africa

09-Feb-2011 - The United States Pharmacopeoia (USP) will help regulators in sub-Saharan Africa ensure drug quality in a new scheme designed to boost testing and analysis capacity.

Bill to tackle prescription drug shortages enters US Senate

09-Feb-2011 - A bill requiring biopharm manufacturers to give the FDA early notification of potential drug shortages has been introduced to the US Senate.

Biosurveillance collaboration can save lives, improve health

08-Feb-2011 - More collaborative biosurveillance could save billions of dollars and millions of lives by, for example, cutting pandemic strain isolation times.

Lotus expands new HQ to house employees

07-Feb-2011 - Lotus Pharmaceuticals’ new HQ in Beijing, China will be even bigger after the firm announces plans for employee apartments.

SPL responds to US FDA warning letter

07-Feb-2011 - US Heparin maker Scientific Protein Laboratories (SPL) says it has resolved “many of the issues” addressed in the US Food and Drug Administration (FDA) warning letter it received late last month.

News in brief

Uganda’s QCI to invest $80m in AIDS and anti-malarial drug capacity

03-Feb-2011 - Ugandan drugmaker Quality Chemicals Industries (QCI) will invest $80m in manufacturing operations to boost capacity for the production of generic AIDS and malaria drugs.

Sign up for your free newsletter

Supplier Webinars